ICREA Research Professor
Since 2010, working as a Principal Investigator at the Cancer Science Program at the Institute for Research in Biomedicine (IRB Barcelona) and since 2013 also as an ICREA Research Professor (Catalan Institute for Research and Advanced Studies).
Dr. Gomis received his PhD in biochemistry from the University of Barcelona in 2002, and was a postdoctoral fellow at Memorial Sloan-Kettering Cancer Center in Prof. Joan Massagué's laboratory. 1997 BSc. University of Barcelona and 2010 BBA Universitat Oberta de Catalunya. In 2007, he assumed his current position. Since 2018 he is an associate professor at the University of Barcelona.
Research activity has focused on how growth factors, signaling pathways, and gene expression programs control normal cell behavior and cancer cell metastasis. Driven by the problem of metastasis, which is the cause of 90% of cancer deaths, the laboratory is pursuing the molecular and genetic mechanisms of metastasis. In 2012 Roger founded Inbiomotion as an ICREA and IRB Barcelona spin-off company. In 2024, the MAF test product reach the market and first patient was tested.